American Society for Radiation Oncology (ASTRO) published its first clinical practice guideline on radiation therapy for ...

Although bladder cancer ranks as the sixth most common cancer in the United States, with approximately 85,000 new cases diagnosed each year, it continues to receive limited awareness, advocacy, and ...

Bladder cancer is mainly urothelial carcinoma, with non-muscle-invasive and muscle-invasive types, and smoking as a key risk factor. Diagnosis involves cystoscopy, biopsy, urine cytology, and imaging ...

Inlexzo is a new treatment for a type of bladder cancer in adults that hasn’t spread to the muscles and doesn’t respond to Bacillus Calmette-Guérin (BCG) therapy. It’s approved for treating non-muscle ...

Researchers developed a urine test that detects bladder cancer, predicts which patients will benefit from immunotherapy ...

The US Food and Drug Administration has approved Johnson & Johnson’s drug delivery system for a type of bladder cancer, offering a potential surgery-free option for patients. The drug release system, ...

Nearly 84,000 Americans will receive a bladder cancer diagnosis this year, yet most people remain unaware of the early warning signs that could save their lives. This silent disease often masquerades ...

A new drug-releasing system, TAR-200, eliminated tumors in 82% of patients in a phase 2 clinical trial for individuals with high-risk non-muscle-invasive bladder cancer whose cancer had previously ...

The extent of the bladder cancer — how far it has spread — matters. Your care team needs to know if your cancer sits on or in the first lining of your bladder (non-muscle invasive), if it goes into ...

Cancer Research: Unlike most liquid biopsies, which look for cancer-related DNA mutations, RNA analysis reveals which genes ...

MORNING COMMUTE. STARTING AT 4:30 A.M. PRO FOOTBALL HALL OF FAMER AND CURRENT COLLEGE FOOTBALL COACH DEION SANDERS REVEALED HE WAS DIAGNOSED WITH AN AGGRESSIVE FORM OF BLADDER CANCER EARLIER THIS YEAR ...